5 mins | 30 mins | Hourly | Daily | Weekly |
---|---|---|---|---|
SELL | SELL | SELL | SELL | SELL |
5 mins | 30 mins | Hourly | Daily | Weekly | |
---|---|---|---|---|---|
MA5 | 1.75▼ | 1.75▼ | 1.74▼ | 1.76▼ | 1.76▼ |
MA10 | 1.75▼ | 1.75▼ | 1.75▼ | 1.78▼ | 1.80▼ |
MA20 | 1.75▼ | 1.75▼ | 1.76▼ | 1.78▼ | 1.77▼ |
MA50 | 1.76▼ | 1.77▼ | 1.79▼ | 1.81▼ | 2.29▼ |
MA100 | 1.77▼ | 1.79▼ | 1.79▼ | 1.79▼ | 2.18▼ |
MA200 | 1.81▼ | 1.83▼ | 1.87▼ | 2.14▼ | N/A |
5 mins | 30 mins | Hourly | Daily | Weekly | |
---|---|---|---|---|---|
MACD | 0.000▼ | 0.001▲ | 0.000▼ | -0.006▼ | 0.035▲ |
RSI | 40.448▼ | 42.442▼ | 41.119▼ | 44.258▼ | 43.523▼ |
STOCH | 66.667 | 41.667 | 38.571 | 16.912▼ | 29.461 |
WILL %R | -100.000▼ | -100.000▼ | -71.429 | -97.059▼ | -76.119▼ |
CCI | -107.498▼ | -134.901▼ | -95.758 | -97.538 | -1.699 |
CDL | $MAIA Doji Candlestick Pattern Detected | Set Alert |
Thursday, June 05, 2025 04:59 PM
MAIA Biotechnology, Inc. (NASDAQ:MAIA) on Thursday revealed updated data from its THIO-101 pivotal Phase 2 clinical trial. The trial is evaluating its lead clinical candidate, ateganosine (THIO ...
|
Thursday, June 05, 2025 11:38 AM
MAIA Biotechnology's Experimental Cancer Drug Shows Tripled Survival Vs. Standard Chemotherapy In Pretreated Lung Cancer Patients MAIA posts 17.8-month median survival in NSCLC trial, nearly ...
|
Thursday, June 05, 2025 11:27 AM
MAIA Biotechnology, Inc. (NASDAQ:MAIA) on Thursday revealed updated data from its THIO-101 pivotal Phase 2 clinical trial. The trial is evaluating its lead clinical candidate, ateganosine (THIO), ...
|
date | open | high | low | close | volume |
---|---|---|---|---|---|
13/06/25 | 1.73 | 1.77 | 1.72 | 1.72 | 59,571 |
12/06/25 | 1.72 | 1.78 | 1.71 | 1.75 | 155,338 |
11/06/25 | 1.77 | 1.84 | 1.73 | 1.75 | 84,482 |
10/06/25 | 1.79 | 1.82 | 1.77 | 1.785 | 114,706 |
09/06/25 | 1.78 | 1.80 | 1.75 | 1.80 | 197,659 |
06/06/25 | 2.01 | 2.04 | 1.7601 | 1.80 | 315,931 |
05/06/25 | 1.95 | 2.05 | 1.85 | 1.95 | 2,350,592 |
04/06/25 | 1.77 | 1.80 | 1.74 | 1.76 | 115,482 |
03/06/25 | 1.72 | 1.79 | 1.71 | 1.75 | 83,713 |
02/06/25 | 1.74 | 1.81 | 1.71 | 1.75 | 143,570 |
|
|
||||
|
|
||||
|
|